B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS · Pharmaceutical manufacturer.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Pharmacy

Issues related to drug pricing. Issues related to PBM reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.